← Back to Patent Explorer
US4215038A Expired / Lapsed US ⏱️ 0.0 years remaining

Peptides which inhibit gonadal function

Assignee: Salk Institute for Biological Studies
•
Filing: 1978-10-16
•
Granted: 1980-07-29
•
Expires: 1998-10-16
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Peptides which inhibit the secretion of gonadotropins by the pituitary gland and inhibit the release of steroids by the gonads. The peptides have the structure: R1-R2-R3-Ser-Tyr-R4-R5-Arg-R6 wherein R1 is selected from the group consisting of D-pGlu, D-Pro, D-Trp, D-His, D-Arg, D-Leu, Formyl D-Pro, Acetyl D-Pro, Benzoyl D-Pro and beta -Ala; R2 is selected from the group consisting of D-Phe, Phe, N alpha Me-Phe, His, D-His, D-Trp, Trp and N alpha Me-Leu; R3 is selected from the group consisting of D-Trp, Trp; D-Phe, Phe, Pro and D-His; R4 is selected from the group consisting of Gly, D-Trp, D-Phe and D-Tyr; R5 is selected from the group consisting of Leu and N alpha Me Leu; and R6 is selected from the group consisting of Pro-Gly-NH2 and Pro-NH-CH2-CH3.

Inventors

  • 👤 Jean E. F. Rivier
  • 👤 Catherine L. Rivier
  • 👤 Wylie W. Vale, Jr.

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-26 00:49
CPC Classifications
C; C07; C07K; C07K7/00; C07K7/04; C07K7/23; C07K7/16; A; A61; A61K; A61K38/00; Y; Y10; Y10S; Y10S930/00; Y10S930/01; Y10S930/13

Claims Analysis

Total Claims: 17
Claim 1
Independent Claim 121 words
A peptide which is effective to inhibit release of steroids by the gonadotropins of mammalians, said peptide having the formula: R.sub.1 -R.sub.2 -R.sub.3 -Ser-Tyr-R.sub.4 -R.sub.5 -Arg-R.sub.6 wherein R 1 is selected from the group consisting of D-pGlu, D-Pro, D-Trp, D-His, D-Arg, D-Leu, formyl D-Pro, acetyl D-Pro, benzoyl D-Pro and β-Ala, R 2 is selected from the group consisting of D-Phe, D-His and D-Trp; R 3 is selected from the group consisting of D-Trp, D-Phe, and D-His; R 4 is selected from the group consisting of D-Trp, D-Phe and D-Tyr; R 5 is selected from the group consisting of Leu and N a Me-Leu; and R 6 is selected from the group consisting of Pro--Gly--NH 2 and Pro--NH--CH 2 --CH 3 .
Claim 2
Dependent Claim 121 words
A peptide which is effective to inhibit release of steroids by the gonadotropins of mammalians, said peptide having the formula: R.sub.1 -R.sub.2 -R.sub.3 -Ser-Tyr-R.sub.4 -R.sub.5 -Arg-R.sub.6 wherein R 1 is selected from the group consisting of D-pGlu, D-Pro, D-Trp, D-His, D-Arg, D-Leu, formyl D-Pro, acetyl D-Pro, benzoyl D-Pro and β-Ala, R 2 is selected from the group consisting of D-Phe, D-His and D-Trp; R 3 is selected from the group consisting of D-Trp, D-Phe, and D-His; R 4 is selected from the group consisting of D-Trp, D-Phe and D-Tyr; R 5 is selected from the group consisting of Leu and N a Me-Leu; and R 6 is selected from the group consisting of Pro--Gly--NH 2 and Pro--NH--CH 2 --CH 3 .
Claim 3
Dependent Claim 35 words
A peptide in accordance with claim 1 wherein R 1 is D-pGlu, R 2 is D-Phe, R 3 is D-Trp, R 4 is D-Trp, R 5 is Leu and R 6 is Pro--Gly--NH 2 .
Claim 4
Dependent Claim 37 words
A peptide in accordance with claim 1 wherein R 1 is D-pGlu, R 2 is D-Phe, R 3 is D-Trp, R 4 is D-Trp, R 5 is N a Me-Leu and R 6 is Pro--Gly--NH 2 .
Claim 5
Dependent Claim 37 words
A peptide in accordance with claim 1 wherein R 1 is D-pGlu, R 2 is D-Phe, R 3 is D-Trp, R 4 is D-Trp, R 5 is Leu and R 6 is Pro--NH--CH 2 --CH 3 .
Claim 6
Dependent Claim 39 words
A peptide in accordance with claim 1 wherein R 1 is D-pGlu, R 2 is D-Phe, R 3 is D-Trp, R 4 is D-Trp, R 5 is N a Me-Leu and R 6 is Pro--NH--CH 2 --CH 3 .
Claim 7
Dependent Claim 35 words
A peptide in accordance with claim 1 wherein R 1 is D-Trp, R 2 is D-Phe, R 3 is D-Trp, R 4 is D-Trp, R 5 is Leu and R 6 is Pro--Gly--NH 2 .
Claim 8
Dependent Claim 35 words
A peptide in accordance with claim 1 wherein R 1 is D-Arg, R 2 is D-Phe, R 3 is D-Trp, R 4 is D-Trp, R 5 is Leu and R 6 is Pro--Gly--NH 2 .
Claim 9
Dependent Claim 35 words
A peptide in accordance with claim 1 wherein R 1 is D-Leu, R 2 is D-Phe, R 3 is D-Trp, R 4 is D-Trp, R 5 is Leu and R 6 is Pro--Gly--NH 2 .
Claim 10
Dependent Claim 35 words
A peptide in accordance with claim 1 wherein R 1 is D-His, R 2 is D-Phe, R 3 is D-Trp, R 4 is D-Trp, R 5 is Leu and R 6 is Pro--Gly--NH 2 .
Claim 11
Dependent Claim 35 words
A peptide in accordance with claim 1 wherein R 1 is D-Pro, R 2 is D-Phe, R 3 is D-Trp, R 4 is D-Trp, R 5 is Leu and R 6 is Pro--Gly--NH 2 .
Claim 12
Dependent Claim 35 words
A peptide in accordance with claim 1 wherein R 1 is D-pGlu, R 2 is D-Phe, R 3 is D-Phe, R 4 is D-Trp, R 5 is Leu and R 6 is Pro--Gly--NH 2 .
Claim 13
Dependent Claim 36 words
A peptide in accordance with claim 1 wherein R 1 is formyl D-Pro, R 2 is D-Phe, R 3 is D-Trp, R 4 is D-Trp, R 5 is Leu and R 6 is Pro--Gly--NH 2 .
Claim 14
Dependent Claim 36 words
A peptide in accordance with claim 1 wherein R 1 is acetyl D-Pro, R 2 is D-Phe, R 3 is D-Trp, R 4 is D-Trp, R 5 is Leu and R 6 is Pro--Gly--NH 2 .
Claim 15
Dependent Claim 36 words
A peptide in accordance with claim 1 wherein R 1 is benzoyl D-Pro, R 2 is D-Phe, R 3 is D-Trp, R 4 is D-Trp, R 5 is Leu and R 6 is Pro--Gly--NH 2 .
Claim 16
Dependent Claim 35 words
A peptide in accordance with claim 1 wherein R 1 is β-Ala, R 2 is D-Phe, R 3 is D-Trp, R 4 is D-Trp, R 5 is Leu and R 6 is Pro--Gly--NH 2 .
Claim 17
Dependent Claim 35 words
A peptide in accordance with claim 1 wherein R 1 is D-pGlu, R 2 is D-Trp, R 3 is D-Trp, R 4 is D-Trp, R 5 is Leu and R 6 is Pro--Gly--NH 2 .

References Cited (Backward Citations)

US4008209A Cited
US3972859A Cited
US3928307A Cited
US4010125A Cited
US4018726A Cited
US4086219A Cited
US4034082A Cited
US4124703A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1983-07-29 1984-01-28 1984-07-29 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1987-07-29 1988-01-28 1988-07-29 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1991-07-29 1992-01-28 1992-07-29 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag